0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Ophthalmic Images |  November 01, 2012
Chlorpromazine-Induced Corneal Toxicity
Victor Koh, MBBS; Wei-Boon Khor, MRCS(Ed); Li Lim, FRCS(Ed)
Arch Ophthalmol. 2012;130(11):1409. doi:10.1001/archophthalmol.2012.475.
Commentary |  April 01, 1999
What Gives Rise to Impaired Smooth Pursuit in the Relatives of Patients With Schizophrenia?
Larry A. Abel, PhD
Arch Ophthalmol. 1999;117(4):522-523. doi:10.1001/archopht.117.4.522.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Psychiatry
Original Article  |  May 8, 2013
Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside:  A Randomized, Double-blind, Placebo-Controlled Trial
Jaime E. C. Hallak, MD, PhD; Joao Paulo Maia-de-Oliveira, MD; Joao Abrao, MD, PhD; et al.
JAMA Psychiatry
Editorial  |  May 8, 2013
Nitric Oxide and Symptom Reduction in Schizophrenia
Joseph T. Coyle, MD
JAMA
Lab Reports  |  May 01, 2013
Signal of Schizophrenia Risk
Tracy Hampton, PhD
JAMA Psychiatry
Original Article  |  March 6, 2013
Neuroimaging Evidence for the Deficit Subtype of Schizophrenia
Aristotle N. Voineskos, MD, PhD, FRCPC; George Foussias, MD, MSc, FRCPC; Jason Lerch, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems